Insulin glargine and lixisenatide and Lopressor HCT
Determining the interaction of Insulin glargine and lixisenatide and Lopressor HCT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: hydrochlorothiazide / metoprolol
Brand name: Lopressor HCT, Dutoprol
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Lopressor Injection
- Insulin glargine and lixisenatide-Lopressor Intravenous
- Insulin glargine and lixisenatide-Lorabid
- Insulin glargine and lixisenatide-Lorabid Pulvules
- Insulin glargine and lixisenatide-Loracarbef
- Insulin glargine and lixisenatide-Loratadine
- Lopressor HCT-Insulin glargine and lixisenatide Subcutaneous
- Lopressor HCT-Insulin glargine, recombinant Subcutaneous
- Lopressor HCT-Insulin glulisine
- Lopressor HCT-Insulin Glulisine (Cartridges and Pens)
- Lopressor HCT-Insulin Glulisine (Vials)
- Lopressor HCT-Insulin glulisine Subcutaneous